A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/70 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2239976
Methods of selectively inhibiting the growth of or killing prostatic cells, using antisense oligonucleotides to prostate specific genes, are disclosed. The oligonucleotides may have natural nucleic acid structures or may be modified oligonucleotides with enhanced stability or tissue specific targeting. The prostate specific genes to which the antisense may be directed include the AR and the .alpha.FGF gene. Pharmaceutical compositions including such antisense oligonucleotides are also described for use in the methods. The methods and products are of particular utility in the treatment of benign prostatic hyperplasia or prostate cancer.
L'invention porte sur un procédé inhibant sélectivement la croissance des cellules prostatiques ou les tuant à l'aide d'oligonucléotides antisens de gènes spécifiques de la prostate. Lesdits oligonucléotides peuvent présenter des structures d'acides nucléiques naturels ou peuvent être des oligonucléotides modifiés à stabilité renforcée ou ciblant des tissus spécifiques. Les gènes spécifiques de la prostate vers lesquels les antisens peuvent être dirigés comportent les gènes AR et .alpha.FGF. L'invention porte également sur des préparations pharmaceutiques comprenant lesdits oligonucléotides antisens utilisées dans ces procédés. Lesdits procédés et produits s'avèrent notamment utiles pour le traitement de l'hypertrophie et du cancer de la prostate.
Swabey Ogilvy Renault
Worcester Foundation For Biomedical Research
Zamecnik Paul A.
LandOfFree
Antisense oligonucleotide chemotherapy for benign... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotide chemotherapy for benign..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotide chemotherapy for benign... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1837261